Alpha 2.0
Login Register
» Articles » PMID: 18395561

Screening for Neuroblastoma: a Resurrected Idea?

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2008 Apr 9
PMID 18395561
Citations 4
Authors
John M Maris
William G Woods
Affiliations
Soon will be listed here.
Citing Articles

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial.

Berthold F, Spix C, Erttmann R, Hero B, Michaelis J, Treuner J JNCI Cancer Spectr. 2021; 5(4).

PMID: 34240006 PMC: 8259619. DOI: 10.1093/jncics/pkab041.

Cancer Progress and Priorities: Childhood Cancer.

Lupo P, Spector L Cancer Epidemiol Biomarkers Prev. 2020; 29(6):1081-1094.

PMID: 32482635 PMC: 9400945. DOI: 10.1158/1055-9965.EPI-19-0941.

Use of Biomarkers in Screening for Cancer.

Duffy M EJIFCC. 2016; 21(1):1-12.

PMID: 27683350 PMC: 4975170.

Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation.

Arscott W, LaBauve A, May V, Wesley U Oncogene. 2008; 28(4):479-91.

PMID: 18978811 PMC: 2633428. DOI: 10.1038/onc.2008.402.